Products Affected - Description
Mannitol injection, American Regent
250 mg/mL, 50 mL vial, 25 count (NDC 00517-4050-25)
Osmitrol injection, Baxter
100 mg/mL, 500 mL premixed bag (NDC 00338-0353-03) - discontinued
150 mg/mL, 500 mL premixed bag (NDC 00338-0355-03) - discontinued
Mannitol injection, BBraun
200 mg/mL, 250 mL premixed bag (NDC 00264-7578-20)
200 mg/mL, 500 mL premixed bag (NDC 00264-7578-10)
Reason for the Shortage
- Hospira had mannitol injection on shortage due to manufacturing delays.
- Fresenius Kabi had mannitol injection on shortage due to increased demand for the product.
- American Regent has mannitol injection on shortage due to manufacturing delays.
- Baxter could not provide a reason for the shortage.
Mannitol injection, Fresenius Kabi
250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25)
Osmitrol injection, Baxter
50 mg/mL, 1000 mL premixed bag (NDC 00338-0351-04)
200 mg/mL, 250 mL premixed bag (NDC 00338-0357-02)
200 mg/mL, 500 mL premixed bag (NDC 00338-0357-03)
Mannitol injection, Hospira
200 mg/mL, 250 mL premixed bag (NDC 00409-7715-02)
200 mg/mL, 500 mL premixed bag (NDC 00409-7715-03)
250 mg/mL, 50 mL vial, 25 count (NDC 00409-4031-01)
Estimated Resupply Dates
- American Regent has mannitol 250 mg/mL 50 mL vials on back order and the company cannot estimate a release date.
- BBraun has mannitol 200 mg/mL 250 mL and 500 mL premixes available on allocation.
March 4, January 21 and 30, 2015; November 19, October 29, September 5 and 24, September 5, August 13 and 28, July 22, May 28, March 27, January 21, 2014; December 5 and 18, October 9 and 24, September 12, August 6, July 18, June 7, May 9, April 3, March 5 and 28, February 6, and January 16, 2013; December 17 and 31, November 20 and 28, October 10, August 17, July 5, May 7 and 18, April 12 and 26, March 21, February 8 and 24, January 25, 2012; December 14 and 28, November 15 and 16, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins